BloodPressureHeartMeds.Org

CorMatrix receives $2.3 million grants under QTDP program to advance ECM technology

April 17, 2017

As many as 30% of doctors said they did not use risk assessment tools at all and nearly 13% of doctors said they did not follow guidelines on the management of cardiovascular risk, citing reasons including time constraints, lack of usefulness and inadequate understanding of risk assessment tools and guidelines as the key reasons.

Professor Julian Halcox, Cardiff University, UK, another of the experts behind the study, concluded: "These systems exist to help doctors identify and manage risk factors well before they become a problem, but we now see that they are widely under-utilised across Europe. It is vital that doctors use these tools effectively to assess and communicate risk whenever they evaluate a patient - in doing so they will help reduce the excessive number of preventable deaths in Europe each year."

The findings announced today at the International Society For Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting are the first results from the study. Further data, including a country-by-country breakdown of results, are expected in 2011. The EURIKA study was funded by AstraZeneca as part of its ongoing commitment to improving the management of CVD and its risk factors. The study was designed, executed and analysed by an independent panel of academic experts from across Europe.

Source: AstraZeneca